This report, ladies and gentlemen, should really make it clear once again that this furtive support for the Government in South Africa must stop.

Vote on the motion for a resolution on membership of committees

Effect of parecoxib (or its active metabolite valdecoxib) on the pharmacokinetics of other medicinal products Treatment with valdecoxib (40 mg twice daily for 7 days) produced a 3 fold increase in plasma concentrations of dextromethorphan (CYP2D6 substrate).

Recommendations concerning co administration

No dose adjustment required.

Increased concentrations of indinavir may result in nephrolithiasis.

Terfenadine and astemizole are contraindicated with boosted or unboosted saquinavir (see section 4.3).

Interaction with Invirase ritonavir not studied.

Recommendations concerning co administration

If no alternative treatment is available, use with careful monitoring.

Concomitant use to be taken into account

To be taken into account with concomitant use

Caution is required with concomitant use.

To be taken into account with concomitant use

Caution is recommended in case of co administration.

No data on concomitant administration of Ambirix with specific hepatitis A immunoglobulin or hepatitis B immunoglobulin have been generated.

Increased methadone dose may be necessary when

A dosage reduction to rifabutin 150 mg every three days is recommended based on experience with low dose ritonavir boosted protease inhibitors.

Caution is needed when it is taken with other medicines.

aminoglycosides (when given concurrently, these preparations must be administered separately)

Our Group preference was to have voted to grant discharge while promoting reform which we accept is also the view of the European Commission.

Prothrombin time (PT) increase (with concomitant vitamin K antagonist therapy).

This would add to the costs shown in the table. By the same token, if the transferred resources are squandered, the outcome would fall short of the growth target.

Caution is advised if CYP3A 4 inhibitors are given concomitantly.

Caution is advised if CYP3A4 inhibitors are given concomitantly.

Therefore, caution is recommended in case of co administration.

Careful monitoring of blood glucose is recommended during coadministration.

Caution is needed when VIRAMUNE is taken at the same time as other medicines.

Tenofovir plasma levels remain unchanged when co administered with Nevirapine.

There is neither scientific rationale for benefit nor experience with the use of systemic haemostatics (e. g. desmopressin, aprotinin, tranexamic acid, aminocaproic acid) in individuals receiving rivaroxaban.

aminoglycosides (when given concurrently, these preparations must be administered separately)

Nevertheless, precaution is recommended if alcohol is taken concomitantly.

Caution must be exercised when giving any other cytotoxic agents, especially myelotoxic agents, at the same time.

particularly in elderly patients and in those treated concurrently with corticosteroids.

Dosing adjustment is only necessary in hepatically impaired patients if concomitant renal impairment is present.

adjustment.

Additional information on hydrochlorothiazide interactions when administered concurrently, the following medicinal products may interact with thiazide diuretics

Grapefruit juice ivabradine exposure was increased by 2 fold following the co administration with

Careful monitoring of therapeutic and adverse effects is recommended when dexamethasone is concomitantly administered with indinavir.

Careful monitoring of therapeutic and adverse effects is recommended when loratidine is concomitantly administered with indinavir ritonavir.

Caution is advised during concomitant administration of EMEND and CYP3A4 substrates.

If the combination is considered necessary, monitoring of the saquinavir plasma levels is strongly encouraged.

Anticoagulants warfarin concentrations may be affected when co administered with Kaletra.

Caution should be exercised when Kaletra is co administered with rosuvastatin.

Cyclosporin, sirolimus (rapamycin) and tacrolimus concentrations may be increased when co administered with Kaletra.